Nadim Ahmed, President and CEO at Cullinan Therapeutics, Inc. (CGEM), sold 8,400 shares at $11.87 ($100K) on 2024-12-24, disclosed to the SEC on 2024-12-27.
Open-market sale of $100k CGEM by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CGEM | SELL | 2025-12-29 | $199K | — | Filing → |
| CGEM | SELL | 2025-02-27 | $214K | — | Filing → |
| CGEM | SELL | 2023-12-27 | $39K | — | Filing → |